Semler Scientific (NASDAQ:SMLR) Trading Down 5.6% – Time to Sell?

Shares of Semler Scientific, Inc. (NASDAQ:SMLR) fell 5.6% during trading on Friday . The stock traded as low as $67.33 and last traded at $67.82. 586,094 shares changed hands during mid-day trading, an increase of 108% from the average session volume of 281,545 shares. The stock had previously closed at $71.84.

Semler Scientific Price Performance

The stock has a market cap of $561.58 million, a PE ratio of 32.40 and a beta of 1.18. The company’s fifty day moving average is $42.98 and its 200-day moving average is $34.45.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The company had revenue of $13.51 million for the quarter.

Institutional Investors Weigh In On Semler Scientific

Hedge funds and other institutional investors have recently made changes to their positions in the company. State Street Corp boosted its holdings in Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after buying an additional 725 shares in the last quarter. CWM LLC boosted its stake in shares of Semler Scientific by 486.3% during the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after acquiring an additional 744 shares in the last quarter. Quest Partners LLC grew its position in shares of Semler Scientific by 48.0% during the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after acquiring an additional 817 shares during the period. Newbridge Financial Services Group Inc. acquired a new position in Semler Scientific in the 2nd quarter worth about $34,000. Finally, US Bancorp DE boosted its position in Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after purchasing an additional 1,158 shares in the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.